Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

NCT03458221 is registered in ClinicalTrials.gov with Gynaecologisch Oncologisch Centrum Zuid as lead sponsor.

NCT NCT03458221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03458221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Lead sponsor
Gynaecologisch Oncologisch Centrum Zuid
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 31, 2023
Completion date
October 1, 2026
Enrollment
148 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ovarian cancer, signal transduction pathway deregulation, therapy-associated cancer